Search Results - "Rare cancers and therapy"
-
1
Evolving Paradigms in the Management of Multiple Myeloma: Novel Agents and Targeted Therapies
Published in Oncology and therapy (2015)“…Multiple myeloma (MM) is a clonal plasma cell disorder defined by bone marrow infiltration and osteolytic bone lesions and is the second most common…”
Get full text
Journal Article -
2
Reviewing Challenges in the Diagnosis and Treatment of Lentigo Maligna and Lentigo-Maligna Melanoma
Published in Oncology and therapy (2015)“…Lentigo maligna (LM) and lentigo-maligna melanoma (LMM) are pigmented skin lesions that may exist on a continuous clinical and pathological spectrum of…”
Get full text
Journal Article -
3
Targeted Therapy in Oropharyngeal Squamous Cell Carcinoma: The Implications of HPV for Therapy
Published in Oncology and therapy (2015)“…Oropharyngeal cancers caused by human papillomaviruses (HPV) have a different epidemiology, prognosis, genetic mutational landscape, response to treatment, and…”
Get full text
Journal Article -
4
Acute Myeloid Leukemia in the Elderly Patient: New Strategies
Published in Oncology and therapy (2015)“…Although selected older adults with acute myeloid leukemia can benefit from intensive therapies, recent evidences support the use of lower-intensity therapies…”
Get full text
Journal Article -
5
Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia
Published in Oncology and therapy (2015)“…Acute promyelocytic leukemia (APL) is a molecularly well-defined disease, characterized by a specific chromosomal translocation; the improvement in biologic…”
Get full text
Journal Article -
6
Treatment of Adult Soft Tissue Sarcomas: An Overview
Published in Oncology and therapy (2015)“…Sarcomas are uncommon malignancies accounting for about 1% of all adult malignancies. Sarcomas are a heterogeneous group of tumors which includes more than 100…”
Get full text
Journal Article -
7
Bosutinib for Chronic Myeloid Leukemia
Published in Oncology and therapy (2015)“…In recent years the availability of several tyrosine kinase inhibitors (TKI) in the therapeutic armamentarium for chronic myeloid leukemia has dramatically…”
Get full text
Journal Article -
8
An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs)
Published in Oncology and therapy (2015)“…Patients suffering from pancreatic neuroendocrine tumors (pNETs) are now candidates to receive novel approved drugs that have demonstrated benefit in disease…”
Get full text
Journal Article -
9
Efficacy and Safety of Aflibercept and Its Role in the Treatment of Metastatic Colorectal Cancer
Published in Rare cancers and therapy (01-12-2013)“…Background Vascular endothelial growth factor (VEGF) and related pathway elements are critically important in the pathogenesis, growth, and development of…”
Get full text
Journal Article -
10
Expression Patterns of Snail1, E-Cadherin and N-Cadherin Proteins in the Developing Kidney and in Wilms’ Tumor (Nephroblastoma)
Published in Rare cancers and therapy (01-12-2014)“…Introduction Snail1 is a transcription factor that suppresses E-cadherin. The roles of Snail1 and E-cadherin in mesenchyme–epithelial transition (MET) are not…”
Get full text
Journal Article -
11
Rectal Melanoma with Multiple Metastases: A Rare and Aggressive Tumor
Published in Rare cancers and therapy (01-12-2014)“…Introduction Rectal melanoma is one type of mucosal melanoma and accounts for fewer than 2% of all mucosal melanomas; it is a rare, aggressive disease with…”
Get full text
Journal Article -
12
Letter from the Editor
Published in Rare cancers and therapy (01-12-2013)Get full text
Journal Article